Skip to main content

U.S. scientists are enrolling nearly 40,000 patients in 4-year $1.2 billion study of long Covid

The study, Recover, aims to complete enrollment of 40,000 people and launch clinical trials on potential treatments by the end of the year.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.